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Abstract  
 This study was focused on the release of TNF- α by cultured 
monocytes of human blood in the absence and presence of D : B Friedo - 
olean - 5 -en- 3α -ol (DBFO). The human monocytes were isolated from the 
peripheral blood mononuclear cells (PBMC). The release of TNF-α by 
monocytes was induced by the addition of lipopolysaccharide (LPS) to the 
culture medium. ELISA Sandwich's method was used to the dosing of TNF-
α concentration. 
The release of TNF-α is inhibited by DBFO. In the absence of DBFO, TNF- 
α concentration is 3.86 ng/ml versus 3.77 ; 3.2 ; 2.79 and 0.89 ng/ml in the 
presence of DBFO at concentrations 1 , 3, 10 and 30 µg/ml respectively ( p 
<0.05) . 
 
Keywords: TNF-α – Monocytes – Lipopolysaccharide (LPS) –D:B-friedo-
olean-5-en-3α-ol (DBFO) 
 
Introduction 
 The presence of antigens and damaged cells, cause inflammation, a 
physiological process of the body defense (Schoroderet M., 1992). This 
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reaction is intended to eliminate the phlogogenic agent and repair the tissue 
damage (Weill B. et al., 2003). 
 The presence of antigens in the organism activates the resident cells 
in connective tissues which release pro-inflammatory mediators such as 
histamine and cytokines including TNF-α (Williams C.M.M and Galli S.J., 
2000; Weill B. et al., 2003). These pro-inflammatory mediators recruit 
monocytes from the bloodstream to the site of inflammation (Descamps -
Latscha B. and Witko -Sarsat V., 1996; Eming S.A. et al., 2007). 
 Andriamampianina T.T. et al. (2015) reported the anti-inflammatory 
activity of D: B- Friedo - olean -5 -en- 3α -ol (DBFO) in vivo. This activity 
could be due to the inhibition of the release of TNF-α (Fiebich B.L. et al., 
2001; Min- Hsiung P. et al., 2016). 
 Therefore, this study is aimed to investigate the DBFO activity on the 
release of TNF-α induced experimentally in vitro by exposing monocytes to 
lipopolysaccharide (LPS). ELISA Sandwich was used to dose the 
concentration of TNF-α released. 
 
Materials  and  methods: 
 The effect of DBFO on the release of TNF- α by monocytes exposed 
to LPS was investigated by dosing TNF-α in the absence and presence of 
DBFO using ELISA Sandwich. 
 
Isolation of monocytes  
 The blood was collected from human healthy donors in heparinized 
tubes and diluted with RPMI 1640 (Lonza BioWhittaker®) (v/v). 
Afterwards, 30 ml of this blood were put in a 50 ml propylene tube 
containing 15 ml of polyfluorocarbon liquid (Ficoll®) (MSL Eurobio 2000). 
The mixture blood - Ficoll® was centrifuged at 600 g for 20 min at room 
temperature (Cosma A. and Allgayer S., 2007). After centrifuging, the 
supernatant was removed and the interphase containing the PBMC was 
aspirated and transferred into a 50 ml propylene tube. 
 This interphase was rinsed with 10 ml of RPMI 1640 and centrifuged 
at 200 g for 15 min at room temperature. After removing the supernatant, the 
pellet was rinsed with 10 ml of RPMI 1640 and centrifuged under the same 
conditions. The final supernatant was discarded and the cells were suspended 
in 1 ml of RPMI (Cosma A. and Allgayer S., 2007 ; Vogel H. G. et al., 
2008). 
 The cell suspension was diluted to 1/10 with a mixture of RPMI 1640 
- Eosin (95: 5). The Eosin was used to differentiate live cells, which were 
counted with a Malassez cell of 1 µl to determine the proportion of 
monocytes and lymphocytes in PBMC (Raulf - Heimsoth M., 2008). 
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 The cell culture was performed in a 48 well plate in which RPMI 
1640 was added as culture medium. Two hundred microliters of suspension 
containing 6.66x106 PBMC were added to each well. The plate was 
incubated for 1 hour at 37° C, with an 85 % humidity, in the presence of 5% 
CO2. At the end of this period, the monocytes adhered at the bottom of the 
well. The non- adherent cells were removed, and the plate was rinsed twice 
with RPMI 1640 to ensure complete removal. The adherent monocytes were 
suspended in RPMI 1640 and counted using a cell Malassez of 1 µl (Wahl 
L.M. et al., 2005; Menck K. et al., 2014). 
  
Effect of DBFO on the release of TNF- α by monocytes 
 Monocytes were cultured in RPMI 1640 supplemented with 0.2% of 
NHS (normal human serum), 2 mM of glutamine and 1% of penicillin-
streptomycin Sigma Aldrich ® (100 UI/ml: 100 µg/mL) (Adib-Conquy M. 
and Cavaillon J.M., 2002). They were divided into 6 sets of 8 wells of 200 µl 
per well. The first set containing monocytes only was used as negative 
control, while the second containing monocytes and LPS at a concentration 
of 1 ng/ml served as a positive control (Gutsmann T. et al., 2001; Adib-
Conquy M. and Cavaillon J.M., 2002). The well of the last 4 sets were 
containing monocytes and LPS.  DBFO was added in a concentrations of 1, 
3, 10 and 30 µg/ml respectively. The plate was incubated for 24 hours at 37 
°C with an 85% humidity and with 5% of CO2. At the end of this period, the 
supernatants were aspirated and transferred to an ELISA plate for TNF-α 
dosage (Cloëz - Tayarani I. et al., 2003). 
 
Dosage of  TNF-α  
 The concentrations of TNF- α in the supernatants were determined by 
sandwich ELISA using a reactionnal kit DuoSet® ELISA Development 
System (RαD Systems Minneapolis, MN) (Okubo A. et al., 1990 ; Chung 
C.H. et al., 2015). 
 To fix the first monoclonal antibody, 100 µl of ELISA buffer 
"capture antibody" prepared in Phosphate buffered saline (PBS) were added 
into each well of the plate ELISA (NUNK, 96 well). The plate was incubated 
at room temperature for 18 hours and washed 3 times with a buffer made of 
0.05% Tween 20 prepared in PBS, to remove the excess antibody. One 
hundred µl of BSA 1% (bovine serum albumin) prepared in PBS (v:v) were 
added into each well. The plate was incubated at room temperature for one 
hour, then emptied. 
 A standard range of recombinant TNF- α was prepared. Eight tubes 
were used. The first tube contained the reagent diluent only, made of 1% 
BSA prepared in PBS. The last 7 tubes contained the recombinant TNF- α at 
concentrations ranging from 1000 pg/ml to 15.6 pg/ml with a geometric 
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dilution of rate 2 in the reagent diluent. The culture supernatants of 
monocytes were diluted to 10th. The standard range and the samples were 
deposited in duplicate in a volume of 100 µl per well. Then the plate was 
incubated at room temperature for 2 hours and washed 3 times with the 
buffer, after the incubation period. 
 The solution of the second antibody containing  biotin was distributed 
in a volume of 100 µl per well. The plate was then incubated at room 
temperature for 2 hours and washed 3 times after the incubation. 
 The streptavidin - HRP® used for recognizing biotin was distributed 
into each well in a volume of 100 µl. The plate was incubated for 20 minutes 
and afterwards washed 3 times. The substrate solution was distributed in a 
volume of 100 µl per well and gave a blue coloration. One hundred µl of 3N 
HCl solution was then added to each well to stop the color reaction. 
 Fifteen minutes after the addition of HCl, the optical density (OD) of 
the content of each well was read with a spectrophotometer (ELISA reader 
DYNEX) at λ = 450 nm. The concentration of TNF- α in the sample was 
determined according to the standard range. 
 
Expression and analysis of results  
 The concentration of TNF- α released was expressed as mean ± 
standard error of mean (s.e.m.). Student “t” test was used to compare the 
means. Differences were considered as significant with a P < 0.05.  
 
Results 
Isolation of monocytes 
 5x103 monocytes per microliter, or 1x106 monocytes in 200 µl was 
noted after counting the cultured cells, indicating that the whole culture 
medium contains 85 % of lymphocytes and 15 % of monocytes. 
 
Effect of  DBFO on the release of TNF-α  
 In the absence of DBFO and LPS, human monocytes don’t release 
TNF- α. The stimulation of monocytes by LPS induces the release of TNF-α 
in the medium. The addition of DBFO in increasing concentration in the 
culture medium containing monocytes and LPS, decreases the concentration 
of TNF-α released. 
 In the presence of 1 ng/ml of LPS, the concentration of TNF- α 
released by these monocytes is equal to 3.86 ng/ml. The addition of DBFO at 
concentrations 1, 3, 10 and 30 µg/ml reduced the concentration of TNF-α 
released to 3.77, 3.2, 2.79 and 0.89 ng/ml respectively (p <0.05) (Figure 1). 
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Figure 1. Variation of the concentration of TNF -α (ng/mL) released by human monocytes 
cultured in absence of LPS, in presence of LPS  and with DBFO  added at concentrations 
of 1,  3, 10 and 30 µg/mL ( ?̅? ± s.e.m., n = 16, * p < 0.05).  
 
Discussion: 
 This work was conducted to study the effect of DBFO on the release 
of TNF- α by monocytes of human blood in vitro. Lipopolysaccharide (LPS) 
was used to stimulate the release of TNF- α by monocytes (Gutsmann T. et 
al, 2001 ; Adib-Conquy M. and Cavaillon J.M., 2002). 
 Shockman G. D. and  Barrett J. F. (1983) reported that 
lipopolysaccharide which is a constituent of the membrane of E. coli 
contains a polyosidic fraction recognized as an antigen by monocytes. LPS 
fragment carries an antigen O. Associated with lipid A, it binds to the 
membrane receptor TLR-4 (Toll - like receptor 4) of monocytes (Reeves P., 
1995 Janeway C.A. et al., 2009). This interaction sends a signal to the cell 
nucleus and activates the nuclear transcription factor which induces the 
release of TNF- α out of monocytes (Miller S.I. and Ernst R.K., 2005). 
 However, in the presence of increasing concentrations of DBFO, this 
release of TNF- α by monocytes decreases. Two hypothesis could be 
advanced to explain this result. Either the DBFO would inhibits TNF-α 
synthesis by preventing the inductor (LPS) to bind to the monocyte 
membrane receptor (Nijland R. et al., 2014), or DBFO would inhibit the 
release of TNF-α  by the monocytes (Kirchner S. et al., 2004). 
 It was reported that Hispidol, a triterpenoids isolated from Ponciri 
Immaturus (Shin E.M. et al, 2010) and Betulin from Boswellia serrata 
inhibit the TNF- α release from monocytes in vitro (Dzubak P. et al., 2006). 
On the other hand, DBFO isolated from Cladogelonium madagascariense 
Leandri, belongs to triterpenoids family and inhibits inflammation evoked by 
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carrageenan in mice (Andriamampianina T.T. et al., 2015). It could be 
advanced that the activity of DBFO, in inhibiting the TNF-α release from 
human monocytes cell, could be due to its chemical nature. 
 
Conclusion 
 The DBFO isolated from Cladogelonium madagascariense Leandri 
inhibits TNF- α released by monocytes stimulated with LPS in vitro. 
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